Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
54.09
+0.72 (1.35%)
At close: Oct 9, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $344.27 billion as of October 9, 2026. Its market cap has increased by 18.15% in one year.
Market Cap
344.27B
Enterprise Value
377.49B
Revenue
77.92B
Global Rank
n/a
Country Rank
n/a
PE Ratio
22.54
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 344.27B, an increase of 3,830.58%. That is a compound annual growth rate of 11.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 344.27B | 3.84% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 783.32M |
| Silence Therapeutics | 573.19M |
| Nika Pharmaceuticals | 431.19M |
| American Oncology Network | 371.06M |
| CytoDyn | 286.35M |
| Elite Pharmaceuticals | 280.06M |
| Northwest Biotherapeutics | 264.03M |
| Glorywin Entertainment Group | 234.77M |